Home / Markets / Themes / GLP-1 Stocks
THEME · RULES BASKET
GLP-1 Stocks List: Obesity and Diabetes Theme Basket
GLP-1 therapies reshaped healthcare and consumer narratives. This theme tracks listed companies with direct GLP-1 products, late-stage pipelines, or clear supply-chain exposure. It is for research navigation — not medical or investment advice.
Rules basket · delayed public quotes · research only · quote mode desk · as-of 2026-10-04T13:14:03 · Markets Desk
Names6
Up / Down0 / 6
Missing quotes0
Constituents
Delayed public quotes. Empty cells stay — — never filled with estimates.
| Ticker | Role | Last | Day % | Volume |
|---|
| LLY Eli Lilly and Company | Incretin franchise | 1,142.85 | -0.61% | 2.1M |
| NVO Novo Nordisk A/S | GLP-1 franchise (ADR) | 37.32 | -0.21% | 10.2M |
| AMGN Amgen Inc. | Obesity pipeline exposure | 403.04 | -1.04% | 3.5M |
| PFE Pfizer, Inc. | Metabolic pipeline / partnerships | 27.80 | -1.14% | 35.0M |
| VKTX Viking Therapeutics, Inc. | Oral / next-gen candidates | 29.94 | -1.87% | 6.3M |
| GPCR Structure Therapeutics Inc. | Oral GLP-1 candidates | 27.67 | -4.52% | 1.7M |
- OpenBB lab offline — Desk mode (Stooq/Yahoo + news tape). Not Bloomberg data.
Methodology
Inclusion is product- and pipeline-driven from public disclosures. The desk does not estimate peak sales. Quote table is equal-weight for scanning only.
Weekly desk note
Saturday pipeline writes theme notes into Prisma Article (Markets Desk). Until the latest note is approved, this hub stays the indexable rules page — not a thin quote dump.
Read today's Daily Brief →
FAQ
- Is VKTX / GPCR as liquid as LLY?
- No. Smaller names can gap and print thin volume. The table still shows delayed quotes when available, and shows — when not.
- Do you include compounders?
- Not as basket members. The theme is public equities with filing-traceable exposure.